SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: john couch who wrote (2611)7/16/1998 5:35:00 PM
From: Brian Moloney  Read Replies (1) of 3725
 
John, I have read the studies about the expanded capabilities using the contrast, but our set-up in town does not yet do that. How many of the US installations are using contrast? How many of the Heartscan installations are using contrast? What additional costs (hardware, software, personnel, etc.) are necessary to get up and running?
To me the use of the contrast material for the "non-invasive heart cath" is extraordinary; the pictures are amazing. It seems to me that most of these studies have been done in Germany, but I may be wrong. My impression is that this use of the technology is barely being used in the US.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News